menu
    • menu

    Company profile for Mallinckrodt Pharmaceuticals

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-02-24

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our visio...
    Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to address unmet patient needs, steming from nearly 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future. Our strong ability to master and manage complexity is the key component in making high-quality products that provide value for patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mallinckrodt PharmaceuticalsIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    College Business & Technology Park Cruiserath, Blanchardstown Dublin 15
    Telephone
    Telephone
    +353 1 6960000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mallinckrodt.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mallinckrodt/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/mnk

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 5465

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

    Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

    First‑in‑class drugs are therapies with entirely new approaches that improve patient outcomes and fundamentally change treatment paradigms.This week, PharmaCompass brings a compilation of 2025’s most promising first-in-class drug candidates. With their US Food and Drug Administration (FDA) action dates in 2025, many of these drugs, once approved, hold the potential of becoming blockbusters.Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten poised to transform patient careIonis’ donidalorsen is an exciting candidate designed to tackle hereditary angioedema (HAE), a rare condition marked by unpredictable and potentially life‑threatening swelling episodes.This novel antisense oligonucleotide works by “silencing” the messenger RNA that codes for prekallikrein — a protein that triggers inflammation leading to swelling. Instead of blocking a protein once it’s made, donidalorsen stops the cell from producing it in the first place. This precision approach could mean fewer infusions and reduced side effects compared to traditional treatments.Another promising candidate is Sanofi and Alnylam Pharmaceuticals’ fitusiran. It employs the technology of small interfering RNA (siRNA) to lower levels of antithrombin — a natural protein that, when in excess, can impair the blood’s ability to clot. By reducing antithrombin, fitusiran rebalances the blood’s clotting process in patients with hemophilia A and B.Similarly, Cytokinetics’ aficamten is designed to treat obstructive hypertrophic cardiomyopathy (oHCM), a condition in which the heart muscle becomes abnormally thick, obstructing blood flow. Aficamten works by inhibiting cardiac myosin, a protein that drives heart muscle contraction. This helps relieve symptoms like shortness of breath and chest pain. If approved, aficamten is expected to rake in annual sales of US$ 2.8 billion by 2030.UroGen, J&J’s candidates eye US$ 5 bn markets; AbbVie, Summit’s meds target lung cancerUroGen Pharma’s UGN‑102 is poised to redefine the treatment of non‑muscle‑invasive bladder cancer. This innovative formulation uses a reverse thermal gel technology that transforms from a liquid into a gel once inside the bladder. This change ensures that the chemotherapeutic agent, mitomycin, remains in contact with the bladder lining for a longer period, increasing its effectiveness at eradicating cancer cells and reducing the risk of recurrence.For patients, UGN‑102 could mean a non‑surgical, outpatient treatment option that is less invasive than traditional surgical methods. If approved, UGN-102 could address a US market of approximately 82,000 patients annually, translating into a market opportunity exceeding US$ 5 billion, according to company estimates.Johnson & Johnson’s nipocalimab is a new treatment aimed at helping people with autoimmune diseases — a group of conditions where the body’s defense system mistakenly attacks its own healthy cells. Nipocalimab works by blocking the neonatal Fc receptor (FcRn), thereby lowering the levels of pathogenic antibodies that drive many autoimmune disorders. J&J had acquired this FcRn blocker in 2020 as part of its US$ 6.5 billion takeover of Momenta Pharmaceuticals. J&J is trialing the drug in as many as 10 indications and expects peak annual sales in excess of US$ 5 billion.AbbVie’s antibody-drug conjugate (ADC), telisotuzumab vedotin, is designed as a “guided-missile” to deliver toxic drugs directly to cancer cells while sparing healthy tissues. Telisotuzumab vedotin targets c‑Met, a receptor that is over-expressed in certain cancers such as non‑small cell lung cancer (NSCLC). There are currently no approved anti-cancer therapies specifically for c-Met over-expressing NSCLC.Summit Therapeutics’ ivonescimab is a cutting‑edge bispecific antibody designed specifically for NSCLC. Unlike traditional therapies that target a single molecule, ivonescimab binds simultaneously to a tumor-specific antigen on cancer cells and to a receptor on T cells, effectively bringing these two together so the body’s own immune system can recognize and attack the tumor. This dual engagement strategy helps overcome common mechanism tumors.Insmed’s Brensocatib is an innovative, first‐in‐class oral inhibitor of dipeptidyl peptidase‑1 (DPP‑1) that targets a key step in the inflammatory cascade. DPP‑1 is responsible for activating neutrophil serine proteases — enzymes that, when overactive, can cause significant lung tissue damage in conditions such as non‑cystic fibrosis bronchiectasis. Brensocatib is expected to clock annual sales of US$ 2.8 billion by 2030.Gepotidacin, an investigational antibiotic developed by GSK, is poised to make a significant impact in the treatment of uncomplicated urinary tract infections (uUTIs) and urogenital gonorrhea. If approved, it would be the first oral antibiotic in a new class for uUTIs in over two decades.Arrowhead, Regenxbio, Ultragenyx address rare, genetic diseasesArrowhead Pharmaceuticals is developing an innovative gene-targeting therapy — plozasiran. This drug uses RNA interference (RNAi) to interrupt the gene responsible for producing apolipoprotein C‑III (APOC3), a protein that regulates blood triglyceride levels. For people with severe hypertriglyceridemia or familial chylomicronemia syndrome (FCS) — a severe and rare genetic disease for which there are currently no FDA‑approved treatments — high triglyceride levels can lead to pancreatitis and other serious cardiovascular issues. Regenxbio’s RGX‑121 is a one‑time gene therapy candidate for Hunter syndrome (MPS 2), a rare, inherited disorder that causes progressive neurological decline. The therapy uses a harmless virus to deliver a functional copy of the gene encoding iduronate‑2‑sulfatase (I2S) directly into the central nervous system. By restoring the missing enzyme, RGX‑121 aims to slow or even reverse the harmful buildup of substances in the brain that drive the disease’s progression.Another promising candidate is Ultragenyx Pharmaceuticals’ one-time intravenous gene therapy UX111 for Sanfilippo syndrome type A (MPS 3A). This devastating disorder, which leads to severe neurodegeneration in children, currently has no effective treatment. UX111 uses an adeno‑associated virus (AAV) to deliver a working copy of the SGSH gene, the deficiency of which is responsible for the disease. By enabling the body to produce the missing enzyme, UX111 holds the promise of slowing or even halting the progression of neurodegeneration.Our viewThis year has already seen several first-in-class approvals, such as Vertex’s suzetrigine (Journavx), a pioneering non‐opioid analgesic redefining pain management; SpringWorks’ mirdametinib (Gomekli), a breakthrough MEK inhibitor for a genetic disorder that often leads to the growth of benign tumors along nerves and; AstraZeneca and Daiichi’s ADC datopotamab deruxtecan (Datroway).Despite the volatile political environment in the US and its impact on federal agencies like the FDA, we are hopeful that many of the first-in-class drugs mentioned in this article will make a debut in 2025. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3455

    https://www.pharmacompass.com/radio-compass-blog/top-first-in-class-drug-candidates-of-2025-ionis-donidalorsen-sanofi-s-fitusiran-cytokinetics-aficamten-await-fda-approval

    #Phispers by PHARMACOMPASS
    27 Feb 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    CVC Completes Acquisition of Therakos from Mallinckrodt
    CVC Completes Acquisition of Therakos from Mallinckrodt

    02 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241202409570/en

    BUSINESSWIRE
    02 Dec 2024
    Share Share
    Mallinckrodt Completes Divestiture of Therakos® Business
    Mallinckrodt Completes Divestiture of Therakos® Business

    02 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-completes-divestiture-of-therakos-business-302319183.html

    PR NEWSWIRE
    02 Dec 2024
    Share Share
    Mallinckrodt Presents Data on TERLIVAZ® for Hepatorenal Syndrome
    Mallinckrodt Presents Data on TERLIVAZ® for Hepatorenal Syndrome

    18 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-presents-data-on-terlivaz-terlipressin-for-injection-in-patients-with-hepatorenal-syndrome-hrs-at-the-2024-american-association-for-the-study-of-liver-diseases-aasld-annual-meeting-302308532.html

    PR NEWSWIRE
    18 Nov 2024
    Share Share
    Mallinckrodt to Present at Jefferies London Healthcare Conference
    Mallinckrodt to Present at Jefferies London Healthcare Conference

    14 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-to-present-at-jefferies-london-healthcare-conference-302305741.html

    PR NEWSWIRE
    14 Nov 2024
    Share Share
    Mallinckrodt Reports Q3 2024 Results & Full-Year Guidance
    Mallinckrodt Reports Q3 2024 Results & Full-Year Guidance

    05 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-plc-reports-third-quarter-2024-financial-results-and-raises-full-year-guidance-302296022.html

    PR NEWSWIRE
    05 Nov 2024
    Share Share
    Mallinckrodt to Present TERLIVAZ® Data at AASLD Annual Meeting
    Mallinckrodt to Present TERLIVAZ® Data at AASLD Annual Meeting

    30 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mallinckrodt-to-present-data-on-terlivaz-terlipressin-for-injection-at-the-2024-american-association-for-the-study-of-liver-diseases-aasld-annual-meeting-302290775.html

    PR NEWSWIRE
    30 Oct 2024
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Mallinckrodt Plc and get a quotation

    Mallinckrodt Plc is a supplier offers 154 products (APIs, Excipients or Intermediates).

    Find a price of Paracetamol bulk with DMF, CEP, JDMF offered by Mallinckrodt Plc

    Find a price of Fentanyl bulk with CEP, JDMF offered by Mallinckrodt Plc

    Find a price of Fentanyl Citrate bulk with CEP, JDMF offered by Mallinckrodt Plc

    Find a price of Amphetamine bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Buprenorphine bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Buprenorphine Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Codeine Phosphate bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Fentanyl Citrate bulk with DMF, JDMF offered by Mallinckrodt Plc

    Find a price of Ioversol bulk with DMF, JDMF offered by Mallinckrodt Plc

    Find a price of Methylphenidate Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Naloxone Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Naltrexone Hydrochloride bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Pethidine Hydrochloride bulk with DMF, JDMF offered by Mallinckrodt Plc

    Find a price of Sufentanil Citrate bulk with DMF, CEP offered by Mallinckrodt Plc

    Find a price of Calcium Stearate API bulk with CEP offered by Mallinckrodt Plc

    Find a price of Methadone Hydrochloride bulk with JDMF offered by Mallinckrodt Plc

    Find a price of Oxycodone Hydrochloride bulk with CEP offered by Mallinckrodt Plc

    Find a price of Amphetamine bulk with DMF offered by Mallinckrodt Plc

    Find a price of Amphetamine Aspartate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Chlorpheniramine bulk with DMF offered by Mallinckrodt Plc

    Find a price of Cocaine Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Codeine Sulfate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Corticotropin bulk with DMF offered by Mallinckrodt Plc

    Find a price of Desmopressin Acetate bulk offered by Mallinckrodt Plc

    Find a price of Dexchloropheniramine Maleate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Dexmethylphenidate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Dihydrocodeine Tartrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Diphenoxylate Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Fentanyl bulk with DMF offered by Mallinckrodt Plc

    Find a price of Gallium Chloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Hydromorphone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Ibuprofen bulk with DMF offered by Mallinckrodt Plc

    Find a price of Indium Trichloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Iotalamic Acid bulk with DMF offered by Mallinckrodt Plc

    Find a price of Ioversol bulk with DMF offered by Mallinckrodt Plc

    Find a price of Leuprolide Acetate bulk offered by Mallinckrodt Plc

    Find a price of Levorphanol Tartrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Lisdexamfetamine Dimesylate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Magnesium bulk with CEP offered by Mallinckrodt Plc

    Find a price of Methadone bulk with DMF offered by Mallinckrodt Plc

    Find a price of Methadone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Methylphenidate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Morphine Sulfate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Nalbuphine Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Nalmefene Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Naltrexone bulk with DMF offered by Mallinckrodt Plc

    Find a price of Naltrexone Methobromide bulk with DMF offered by Mallinckrodt Plc

    Find a price of Noscapine bulk with DMF offered by Mallinckrodt Plc

    Find a price of Octreoscan bulk with DMF offered by Mallinckrodt Plc

    Find a price of Opium bulk with DMF offered by Mallinckrodt Plc

    Find a price of Oxycodone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Oxymorphone bulk with DMF offered by Mallinckrodt Plc

    Find a price of Oxymorphone Hydrochloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of Paracetamol bulk with DMF offered by Mallinckrodt Plc

    Find a price of Pentetic Acid bulk with DMF offered by Mallinckrodt Plc

    Find a price of Sodium Molybdate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Sufentanil Citrate bulk with DMF offered by Mallinckrodt Plc

    Find a price of Thallium Chloride bulk with DMF offered by Mallinckrodt Plc

    Find a price of DCI-90 bulk with DMF offered by Mallinckrodt Plc

    Find a price of Konpappu L bulk with JDMF offered by Mallinckrodt Plc

    Find a price of Acetoxyacetyl Chloride bulk offered by Mallinckrodt Plc

    Find a price of Aciclovir bulk offered by Mallinckrodt Plc

    Find a price of Amphetamine bulk offered by Mallinckrodt Plc

    Find a price of Benzphetamine bulk offered by Mallinckrodt Plc

    Find a price of Butalbital bulk offered by Mallinckrodt Plc

    Find a price of Calcitonin bulk offered by Mallinckrodt Plc

    Find a price of Chlorzoxazone bulk offered by Mallinckrodt Plc

    Find a price of Codeine Sulfate bulk offered by Mallinckrodt Plc

    Find a price of Dextropropoxyphene bulk offered by Mallinckrodt Plc

    Find a price of Disodium Hydrogen Phosphate bulk offered by Mallinckrodt Plc

    Find a price of Docusate Potassium bulk offered by Mallinckrodt Plc

    Find a price of Docusate Sodium bulk offered by Mallinckrodt Plc

    Find a price of Doxylamine Succinate bulk offered by Mallinckrodt Plc

    Find a price of Exenatide bulk offered by Mallinckrodt Plc

    Find a price of Exenatide Synthetic bulk offered by Mallinckrodt Plc

    Find a price of Fentanyl Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Ferrous Fumarate bulk offered by Mallinckrodt Plc

    Find a price of Gadoversetamide bulk offered by Mallinckrodt Plc

    Find a price of Gallium Chloride bulk offered by Mallinckrodt Plc

    Find a price of Hydrocodone Bitartrate bulk offered by Mallinckrodt Plc

    Find a price of Hydromorphone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Ibuprofen bulk offered by Mallinckrodt Plc

    Find a price of Indium bulk offered by Mallinckrodt Plc

    Find a price of Iotalamic Acid bulk offered by Mallinckrodt Plc

    Find a price of Isosorbide Dinitrate bulk offered by Mallinckrodt Plc

    Find a price of Lenperone bulk offered by Mallinckrodt Plc

    Find a price of Levorphanol Tartrate bulk offered by Mallinckrodt Plc

    Find a price of Lisdexamfetamine Dimesylate bulk offered by Mallinckrodt Plc

    Find a price of Methadone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Morphine Sulfate bulk offered by Mallinckrodt Plc

    Find a price of Nalbuphine Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Naltrexone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Naltrexone Methobromide bulk offered by Mallinckrodt Plc

    Find a price of Natriuretic Peptide, Brain bulk offered by Mallinckrodt Plc

    Find a price of Noscapine bulk offered by Mallinckrodt Plc

    Find a price of Octreoscan bulk offered by Mallinckrodt Plc

    Find a price of Oxycodone Terephthalate bulk offered by Mallinckrodt Plc

    Find a price of Oxymorphone Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Paracetamol bulk offered by Mallinckrodt Plc

    Find a price of Pemoline bulk offered by Mallinckrodt Plc

    Find a price of Pentazocine bulk offered by Mallinckrodt Plc

    Find a price of Perflutren bulk offered by Mallinckrodt Plc

    Find a price of Pethidine Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Potassium Chloride bulk offered by Mallinckrodt Plc

    Find a price of Potassium Iodide bulk offered by Mallinckrodt Plc

    Find a price of Potassium Nitrate bulk offered by Mallinckrodt Plc

    Find a price of Pramlintide bulk offered by Mallinckrodt Plc

    Find a price of Propoxyphene Napsylate bulk offered by Mallinckrodt Plc

    Find a price of Pseudoephedrine bulk offered by Mallinckrodt Plc

    Find a price of Pseudoephedrine Hydrochloride bulk offered by Mallinckrodt Plc

    Find a price of Reserpine bulk offered by Mallinckrodt Plc

    Find a price of Selenium Methionine bulk offered by Mallinckrodt Plc

    Find a price of Silicon Dioxide API bulk offered by Mallinckrodt Plc

    Find a price of Silver Sulfadiazine bulk offered by Mallinckrodt Plc

    Find a price of Sodium Bitartrate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Dihydrogen Phosphate Monohydrate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Fluoride bulk offered by Mallinckrodt Plc

    Find a price of Sodium Iodide bulk offered by Mallinckrodt Plc

    Find a price of Sodium Perrhenate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Sulfate bulk offered by Mallinckrodt Plc

    Find a price of Sodium Zomepirac bulk offered by Mallinckrodt Plc

    Find a price of Strontium Nitrate bulk offered by Mallinckrodt Plc

    Find a price of Tetrahydrocannabinol bulk offered by Mallinckrodt Plc

    Find a price of Thallium Chloride bulk offered by Mallinckrodt Plc

    Find a price of Theophylline bulk offered by Mallinckrodt Plc

    Find a price of Tolmetin Sodium bulk offered by Mallinckrodt Plc

    Find a price of Ziconotide bulk offered by Mallinckrodt Plc

    Find a price of FACILITIES-PERSONNEL-GEN. OPERATING PROCEDURES RALEIGH NC CHEM. PLANT bulk offered by Mallinckrodt Plc

    Find a price of MANUFACTURING & CONTROLS FOR LEVO ALPHA METHADYL ACETATE HYDROCHLORIDE bulk offered by Mallinckrodt Plc

    Find a price of GASTROMARK (FERUMOXSIL) BOWEL MARKER bulk offered by Mallinckrodt Plc

    Find a price of DEXTROCET-N2000 bulk offered by Mallinckrodt Plc

    Find a price of CT50034 bulk offered by Mallinckrodt Plc

    Find a price of MERCURY 195M/GOLD 195M GENERATORS-FACILS,METHDS,CONTRL FOR PREPARATION bulk offered by Mallinckrodt Plc

    Find a price of COMPAP (TM) bulk offered by Mallinckrodt Plc

    Find a price of PRODUCTION OF TALLOUS T1-201 CHL AT THE BURLINGAME, CA bulk offered by Mallinckrodt Plc

    Find a price of FACILITIES, PERSONNEL,AND G.O.P. FOR THE ST. LOUIS, MISSOURI PLANT bulk offered by Mallinckrodt Plc

    Find a price of MOLYDENUM 99:TECHNETIUM-99M bulk offered by Mallinckrodt Plc

    Find a price of HEXABRIX X-RAY CONTRAST MEDIA bulk offered by Mallinckrodt Plc

    Find a price of PROSAPTIDE bulk offered by Mallinckrodt Plc

    Find a price of INVESTIGATIONAL DRUGS bulk offered by Mallinckrodt Plc

    Find a price of FACILS & PERSONNEL FOR THE RAD PHARM INC CYCLOTRIN ON MAHLER RD. CA. bulk offered by Mallinckrodt Plc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN PETTEN, HOLLAND FACILITY. bulk offered by Mallinckrodt Plc

    Find a price of CYCLOTRON FACILITY-MARYLAND HEIGHTS, MO. bulk offered by Mallinckrodt Plc

    Find a price of MANUFACTURING FACILITY AT RALEIGH, NORTH CAROLINA bulk offered by Mallinckrodt Plc

    Find a price of FACILITIES, PROCEDURES AND PERSONNEL bulk offered by Mallinckrodt Plc

    Find a price of X-RAY CONTRAST MEDIA bulk offered by Mallinckrodt Plc

    Find a price of PROSAPTIDE TX 14(A), CODE 8200 bulk offered by Mallinckrodt Plc

    Find a price of BIOLOGICAL INDICATOR PROGRAM APPLIED MARYLAND HEIGHTS, MO PLANT SITE bulk offered by Mallinckrodt Plc

    Find a price of CODACET-60 (TM) bulk offered by Mallinckrodt Plc

    Find a price of SOD. IODIDE I-123 RADIOCHEM. SOL.-BURLINGAME,CA-(DMF FORMERLY RADPHARM bulk offered by Mallinckrodt Plc

    Find a price of Codeine Phosphate bulk offered by Mallinckrodt Plc

    Find a price of Dihydrocodeine Tartrate bulk offered by Mallinckrodt Plc

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search